- #911398
- 1,415
- Merck #00006483703
Pneumovax® 23 Pneumonia Vaccine Indicated for People 50 Years of Age and Older Pneumococcal 23 Vaccine Polyvalent 25 mcg / 0.5 mL Injection Prefilled Syringe 0.5 mL
PNEUMOVAX, SYR 0.5ML (10/CT)
Features
- PNEUMOVAX 23 is a vaccine indicated for active immunization for the prevention of pneumococcal disease caused by the 23 serotypes contained in the vaccine
- PNEUMOVAX 23 is approved for use in persons 50 years of age or older and persons aged >2 years who are at increased risk for pneumococcal disease
- Box of 10 single-dose, pre-filled Luer-Lok™ syringes with tip caps, color coded with a violet plunger rod and purple stripe on the syringe labels and cartons
- More …
Container Type
Prefilled Syringe Single-Dose VialProduct Details Email
Product Specifications
McKesson # | 911398 |
---|---|
Manufacturer # | 00006483703 |
Brand | Pneumovax® 23 |
Manufacturer | Merck |
Country of Origin | United States |
Application | Pneumonia Vaccine |
Container Type | Prefilled Syringe |
Dosage Form | Injection |
Generic Drug Code | 43859 |
Generic Drug Name | Pneumococcal 23 Vaccine Polyvalent |
NDC Number | 00006483703 |
Product Dating | McKesson Acceptable Dating: we will ship >= 180 days |
Storage Requirements | Requires Refrigeration |
Strength | 25 mcg / 0.5 mL |
Type | Intramuscular or Subcutaneous |
UNSPSC Code | 51201615 |
User | Indicated for People 50 Years of Age and Older |
Volume | 0.5 mL |
Features
- PNEUMOVAX 23 is a vaccine indicated for active immunization for the prevention of pneumococcal disease caused by the 23 serotypes contained in the vaccine
- PNEUMOVAX 23 is approved for use in persons 50 years of age or older and persons aged >2 years who are at increased risk for pneumococcal disease
- Box of 10 single-dose, pre-filled Luer-Lok™ syringes with tip caps, color coded with a violet plunger rod and purple stripe on the syringe labels and cartons
- Store unopened and opened vials at 2° - 8°C (36° - 46°F)
More Information
Professionals Also Viewed

- #842097
- 207
- Pfizer (RSV Vaccines) #00005197105
- In children 6 weeks through 5 years of age, Prevnar 13 is indicated fo …
- In children Prevnar is also indicated for active immunization for the …
- No otitis media efficacy data are available for serotypes 1, 3, 5, 6A, …

- #795986
- 797
- Pfizer (RSV Vaccines) #00005197102
- In children 6 weeks through 5 years of age, Prevnar 13 is indicated fo …
- In children Prevnar is also indicated for active immunization for the …
- No otitis media efficacy data are available for serotypes 1, 3, 5, 6A, …

- #1199151
- 1,933
- Pfizer (RSV Vaccines) #00005200010
- 10 Per Package